PCMT1 and breast cancer: The KM survival curve was drawn based on the TCGA data set and showed that high PCMT1 expression may be a risk factor for poor prognosis in breast cancer patients (HR: 1.92 (1.38, 2.67), P = 0.0001) (Figure 7(b)).